Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BAK Economics is an independent Swiss economic research institute that provides empirical analysis, forecasts, and consulting services. The firm is a leading authority on the economic impact and competitiveness of the Swiss life sciences and pharmaceutical industries, frequently publishing specialized reports on the Basel healthcare cluster. Its services include regional and sectoral benchmarking, economic impact assessments, and strategic market intelligence for both public and private sector clients. By tracking innovation capacity and value-added contributions, BAK Economics serves as a critical data provider for stakeholders in the global biotech and pharma ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BAK Basel Economics.